147 related articles for article (PubMed ID: 37209638)
1. Non-fused imidazole-biphenyl analogs repress triple-negative breast cancer growth by mainly stabilizing the c-MYC G-quadruplex via a multi-site binding mode.
Wang XD; Wang JX; Yu BY; Zhang SQ; Hu MH
Bioorg Med Chem; 2023 Jun; 88-89():117336. PubMed ID: 37209638
[TBL] [Abstract][Full Text] [Related]
2. New substituted quinoxalines inhibit triple-negative breast cancer by specifically downregulating the c-MYC transcription.
Hu MH; Wu TY; Huang Q; Jin G
Nucleic Acids Res; 2019 Nov; 47(20):10529-10542. PubMed ID: 31584090
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Evaluation of New Sugar-Substituted Imidazole Derivatives as Selective
Li ML; Yuan JM; Yuan H; Wu BH; Huang SL; Li QJ; Ou TM; Wang HG; Tan JH; Li D; Chen SB; Huang ZS
J Med Chem; 2022 Oct; 65(19):12675-12700. PubMed ID: 36121464
[No Abstract] [Full Text] [Related]
4. New Dibenzoquinoxalines Inhibit Triple-Negative Breast Cancer Growth by Dual Targeting of Topoisomerase 1 and the
Hu MH; Lin JH
J Med Chem; 2021 May; 64(10):6720-6729. PubMed ID: 33961424
[TBL] [Abstract][Full Text] [Related]
5. Phenanthroline-bis-oxazole ligands for binding and stabilization of G-quadruplexes.
Medeiros-Silva J; Guédin A; Salgado GF; Mergny JL; Queiroz JA; Cabrita EJ; Cruz C
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt B):1281-1292. PubMed ID: 27865994
[TBL] [Abstract][Full Text] [Related]
6. A drug-like imidazole-benzothiazole conjugate inhibits malignant melanoma by stabilizing the c-MYC G-quadruplex.
Wu TY; Huang Q; Huang ZS; Hu MH; Tan JH
Bioorg Chem; 2020 Jun; 99():103866. PubMed ID: 32330737
[TBL] [Abstract][Full Text] [Related]
7. Phenanthroline polyazamacrocycles as G-quadruplex DNA binders.
Carvalho J; Quintela T; Gueddouda NM; Bourdoncle A; Mergny JL; Salgado GF; Queiroz JA; Cruz C
Org Biomol Chem; 2018 Apr; 16(15):2776-2786. PubMed ID: 29611599
[TBL] [Abstract][Full Text] [Related]
8. Rational design of small-molecules to recognize G-quadruplexes of c-MYC promoter and telomere and the evaluation of their in vivo antitumor activity against breast cancer.
Long W; Zheng BX; Li Y; Huang XH; Lin DM; Chen CC; Hou JQ; Ou TM; Wong WL; Zhang K; Lu YJ
Nucleic Acids Res; 2022 Feb; 50(4):1829-1848. PubMed ID: 35166828
[TBL] [Abstract][Full Text] [Related]
9. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.
Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH
J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069
[TBL] [Abstract][Full Text] [Related]
10. Constructing triazole-modified quinazoline derivatives as selective c-MYC G-quadruplex ligands and potent anticancer agents through click chemistry.
Cai JH; Yang DY; Zhang JJ; Tan JH; Huang ZS; Chen SB
Bioorg Chem; 2024 Mar; 144():107173. PubMed ID: 38335759
[TBL] [Abstract][Full Text] [Related]
11. Drug-like biimidazole derivatives dually target c-MYC/BCL-2 G-quadruplexes and inhibit acute myeloid leukemia.
Hu MH; Yu BY; Wang X; Jin G
Bioorg Chem; 2020 Nov; 104():104264. PubMed ID: 32920366
[TBL] [Abstract][Full Text] [Related]
12. Insight Derived from Molecular Dynamics Simulation into the Selectivity Mechanism Targeting
Wang Z; Li G; Tian Z; Lou X; Huang Y; Wang L; Li J; Hou T; Liu JP
J Phys Chem B; 2020 Nov; 124(44):9773-9784. PubMed ID: 33089692
[TBL] [Abstract][Full Text] [Related]
13. Ligand-induced conformational preorganization of loops of c-MYC G-quadruplex DNA and its implications in structure-specific drug design.
Harikrishna S; Kotaru S; Pradeepkumar PI
Mol Biosyst; 2017 Jul; 13(8):1458-1468. PubMed ID: 28650023
[TBL] [Abstract][Full Text] [Related]
14. Microwave-assisted synthesis of phenanthroimidazole derivatives as stabilizer of c-myc G-quadruplex DNA.
Liao S; Zhang Z; Wu Q; Wang X; Mei W
Bioorg Med Chem; 2014 Nov; 22(22):6503-8. PubMed ID: 25440731
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a fluorescent, long chain-bridged bispurine that selectively targets the c-MYC G-quadruplex.
Hu MH; Lin JH; Huang Q
Bioorg Chem; 2022 May; 122():105750. PubMed ID: 35325695
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Evaluation of New Selective NM23-H2 Binders as c-MYC Transcription Inhibitors via Disruption of the NM23-H2/G-Quadruplex Interaction.
Wang YQ; Huang ZL; Chen SB; Wang CX; Shan C; Yin QK; Ou TM; Li D; Gu LQ; Tan JH; Huang ZS
J Med Chem; 2017 Aug; 60(16):6924-6941. PubMed ID: 28714689
[TBL] [Abstract][Full Text] [Related]
17. Piperine analogs arrest c-myc gene leading to downregulation of transcription for targeting cancer.
Pandya N; Kumar A
Sci Rep; 2021 Nov; 11(1):22909. PubMed ID: 34824301
[TBL] [Abstract][Full Text] [Related]
18. Human MYC G-quadruplex: From discovery to a cancer therapeutic target.
Wang W; Hu S; Gu Y; Yan Y; Stovall DB; Li D; Sui G
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188410. PubMed ID: 32827579
[TBL] [Abstract][Full Text] [Related]
19. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression.
Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS
ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961
[TBL] [Abstract][Full Text] [Related]
20. Gaining Insights on the Interactions of a Class of Decorated (2-([2,2'-Bipyridin]-6-yl)phenyl)platinum Compounds with c-Myc Oncogene Promoter G-Quadruplex and Other DNA Structures.
Savva L; Fossépré M; Keramidas O; Themistokleous A; Rizeq N; Panagiotou N; Leclercq M; Nicolaidou E; Surin M; Hayes SC; Georgiades SN
Chemistry; 2022 Sep; 28(54):e202201497. PubMed ID: 35726630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]